Evidence for a phosphorylation site in cytomegalovirus glycoprotein gB

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5716-5719

  Norais, Nathalie ^a   Hall, John A ^a   Gross, Laurie ^a   Tang, Dazhi ^a   Kaur, Surinder ^a   Chamberlain, Scott H ^a   Burke, Rae Lyn ^a   Marcus, Frank ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CYTOMEGALOVIRUS VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; SERINE; SYNTHETIC PEPTIDE; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY TITER; ARTICLE; ENZYME SUBSTRATE; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS NEUTRALIZATION;

EID: 0029900656     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5716-5719.1996     Document Type: Article

References (23)

1. Alder, S. P. Infectious agents and disease, in press.
2. Allen, G. 1981. Sequencing of proteins and peptides, p. 53. Elsevier, Amsterdam.
3. Allende, J. E. Personal communication.
4. Allende, J. E., and C. C. Allende. 1995. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 9:313-323.
5. Biemann, K. 1990. Nomenclature for peptide fragment ions (positive ions). Methods Enzymol. 193:886-887.
6. Britt, W. J., L. Vugler, E. J. Butfiloski, and E. B. Stephens. 1990. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J. Virol. 64:1079-1085.
7. Fenn, J. B., M. Mann, C. K. Meng, S. F, Wong, and C. M. Whitehouse. 1989. Electrospray ionization for mass spectrometry of large biomolecules. Science 246:64-71.
8. Hunt, D. F., J. R. Yates III, J. Shabanowitz, S. Winston, and C. H. Hauer. 1986. Protein sequencing by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 83:6233-6237.
9. Kongsuwan, K., C. T. Prideaux, M. A. Johnson, M. Sheppard, and K. J. Fahey. 1991. Nucleotide sequence of the gene encoding infectious laryngotracheitis virus glycoprotein B. Virology 184:404-410.
10. Kuenzel, E. A., J. A. Mulligan, J. Sommercorn, and E. G. Krebs. 1987. Substrate specificity determinants for casein kinase II as deduced from studies with synthetic peptides. J. Biol. Chem. 262:9136-9140.
11. Marcus, F., J. Rittenhouse, L. Moberly, I. Edelstein, E. Hiller, and D. T. Rogers. 1988. Yeast (Saccharomyces cerevisiae) fructose-1,6-bisphosphatase. Properties of phospho and dephospho forms and of two mutants in which serine 11 has been changed by site-directed mutagenesis. J. Biol. Chem. 263:6058-6062.
12. Navarro, D., P. Paz, S. Tugizov, K. Topp, J. La Vail, and L. Pereira. 1993. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 197:143-158.
13. Oray, B., M. Jahani, and R. W. Gracy. 1982. High-sensitivity peptide mapping of triosephosphate isomerase: a comparison of high-performance liquid chromatography with two dimensional thin-layer methods. Anal. Biochem. 125:131-138.
14. Pinna, L. A. 1990. Casein kinase 2: an "eminence grise" in cellular regulation? Biochim. Biophys. Acta 1054:267-284.
15. Rapp, M., M. Messerle, B. Bühler, M. Tannheimer, G. M. Keil, and U. H. Koszinowski. 1992. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. J. Virol. 66: 4399-4406.
16. Ross, L. J. N., M. Sanderson, S. D. Scott, M. M. Binns, T. Doel, and B. Milne. 1989. Nucleotide sequence and characterization of the Marek's disease virus homologue of glycoprotein B of herpes simplex virus. J. Gen. Virol. 170:1789-1804.
17. Spaete, R. R. 1991. A recombinant subunit vaccine approach to HCMV vaccine development. Transplant. Proc. 23:90-96.
18. Spaete, R. R., A. Saxena, P. I. Scott, G. J. Song, W. S, Probert, W. J. Britt, W. Gibson, L. Rasmussen, and C. Pachl. 1990. Sequence requirements for proteolytic processing of glycoprotein B of human cytomegalovirus strain Towne. J. Virol. 64:2922-2931.
19. Spaete, R. R., R. M. Thayer, W. S. Probert, F. R. Masiarz, S. H. Chamberlain, L. Rasmussen, T. C. Merigan, and C. Pachl. 1988. Human cytomegalovirus strain Townc glycoprotein B is processed by proteolytic cleavage. Virology 16:207-225.
20. Stone, K. L., M. B. LoPresti, N. D. Williams, J. M. Crawford, R. DeAngelis, and K. R. Williams. 1989. Enzymatic digestion of proteins and HPLC peptide isolation in the subnanomole range, p. 377-391. In T. E. Hugh (ed.), Techniques in protein chemistry. Academic Press, Orlando, Fla.
21. Tugizov, S., Y. Wang, I. Qadri, D. Navarro, E. Maidji, and L. Pereira. 1995. Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation. Virology 209:580-591.
22. Yow, M. D., and G. J. Demmler. 1992. Congenital cytomegalovirus disease: 20 years is long enough. N. Engl. J. Med. 326:702-703.
23. Zaia, J. A. 1991. Pathogenesis of CMV-associated disease in 1990. Transplant. Proc. 23:1-4.